NATIONAL BUREAU OF ECONOMIC RESEARCH
NATIONAL BUREAU OF ECONOMIC RESEARCH

Amir Attaran

Faculty of Law, Institute of Population Health
University of Ottawa
57 Louis Pasteur St Ottawa, Ontario K1N 6N5

E-Mail: EmailAddress: hidden: you can email any NBER-related person as first underscore last at nber dot org

NBER Working Papers and Publications

September 2014Poor Quality Drugs and Global Trade: A Pilot Study
with Roger Bate, Ginger Zhe Jin, Aparna Mathur: w20469
Experts claim that some Indian drug manufacturers cut corners and make substandard drugs for markets with non-existent, under-developed or emerging regulatory oversight, notably Africa. This paper assesses the quality of 1470 antibiotic and tuberculosis drug samples that claim to be made in India and were sold in Africa, India, and five mid-income non-African countries. We find that 10.9% of those products fail a basic assessment of active pharmaceutical ingredients (API), and the majority of the failures are substandard (7%) as they contain some correct API but the amount of API is under-dosed. The distribution of these substandard products is not random: they are more likely to be found as unregistered products in Africa than in India or non-African countries. Since this finding is robus...

Published: Roger Bate & Ginger Zhe Jin & Aparna Mathur & Amir Attaran, 2016. "Poor-Quality Drugs and Global Trade: A Pilot Study," American Journal of Health Economics, vol 2(3), pages 373-398.

 
Publications
Activities
Meetings
NBER Videos
Themes
Data
People
About

National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email: info@nber.org

Contact Us